Literature DB >> 16288199

The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.

Mehdi Motallebipour1, Alvaro Rada-Iglesias, Mattias Jansson, Claes Wadelius.   

Abstract

PURPOSE: Nitric oxide has many beneficial functions in the human body at the right amounts, but it can also be hazardous if it is produced in amounts more than needed and has therefore been studied in relation to several neurological and non-neurological disorders. In vitro and in vivo studies demonstrate a connection between the inducible form of Nitric Oxide Synthase, iNOS, and the neuropathological disorder glaucoma, one of the major causes of blindness in the world. In this study, we sought to establish the genetic association between iNOS and primary open angle glaucoma, POAG, and to find the functional element(s) connected with the pathogenesis of the disease.
METHODS: Two microsatellites, 1 insertion/deletion, and 8 single nucleotide polymorphisms (SNPs) in the regulatory region of iNOS were genotyped in 200 POAG patients and 200 age-matched controls. Also, the CCTTT-microsatellite was examined for its protein-binding capability in an electrophoretic mobility shift assay, EMSA.
RESULTS: There was a significant difference in allele distribution of the CCTTT-microsatellite, between patients and controls. (CCTTT)14, which has been reported to have a higher activity in a reporter-construct, was significantly more abundant in POAG patients, while (CCTTT)10 and (CCTTT)13 were less common. In EMSA, the (CCTTT)14 allele exhibited specific binding of nuclear proteins.
CONCLUSIONS: These results, together with other studies on this gene and the CCTTT-microsatellite, establish, for the first time, a genetic association of iNOS with POAG and suggest a regulatory function for the microsatellite.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288199

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  12 in total

1.  Two polypyrimidine tracts in the nitric oxide synthase 2 gene: similar regulatory sequences with different properties.

Authors:  Mehdi Motallebipour; Alvaro Rada-Iglesias; Gunnar Westin; Claes Wadelius
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

Review 2.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Capillary electrophoretic assay for nitrate levels in the vitreous of proliferative diabetic retinopathy.

Authors:  Leyi Gao; Jose S Pulido; R Mark Hatfield; Robert F Dundervill; Colin A McCannel; Scott A Shippy
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-13       Impact factor: 3.205

4.  Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork.

Authors:  Jintao Cheng; Jiamei Liang; Jinze Qi
Journal:  Exp Ther Med       Date:  2017-06-02       Impact factor: 2.447

Review 5.  Complex genetic mechanisms in glaucoma: an overview.

Authors:  Kollu N Rao; Srujana Nagireddy; Subhabrata Chakrabarti
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

Review 6.  Neuroprotection in glaucoma.

Authors:  Sushil K Vasudevan; Viney Gupta; Jonathan G Crowston
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

7.  Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma.

Authors:  N Calandrella; C De Seta; G Scarsella; G Risuleo
Journal:  Cell Death Dis       Date:  2010-08-05       Impact factor: 8.469

Review 8.  Current concepts in the pathophysiology of glaucoma.

Authors:  Renu Agarwal; Suresh K Gupta; Puneet Agarwal; Rohit Saxena; Shyam S Agrawal
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

9.  Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.

Authors:  Richard T Libby; Gareth R Howell; Iok-Hou Pang; Olga V Savinova; Adrienne K Mehalow; Joseph W Barter; Richard S Smith; Abbot F Clark; Simon W M John
Journal:  BMC Neurosci       Date:  2007-12-19       Impact factor: 3.288

Review 10.  The dual role of iNOS in cancer.

Authors:  Federica Vannini; Khosrow Kashfi; Niharika Nath
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.